Astrazeneca AZN
NYSE AZN
$159.18 +0.57 (+0.36%)
At close: Oct 9, 2026 · 4:00 PM EDT

Astrazeneca (AZN) Depreciation & Amortization (CF) (2009 - 2026)

Updated

Astrazeneca's Depreciation & Amortization (CF) came in at $1.93 billion for Q2 2026, up 38.9% from $1.39 billion a year earlier and up 41.2% from the prior quarter.

Analysis

Astrazeneca (AZN) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Astrazeneca reported Depreciation & Amortization (CF) of $6.36 billion, down 6.9% year-over-year; for FY2025, it was $5.73 billion, down 14.3% from FY2024.

  • Depreciation & Amortization (CF) carries a five-year compound annual growth rate of 12.7% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $6.69 billion in FY2024 (+24.2%), $5.39 billion in FY2023 (-1.7%), $5.48 billion in FY2022 (-16.1%) and $6.53 billion in FY2021 (+107.4%).
  • The Q2 2026 figure represents the highest quarterly Depreciation & Amortization (CF) since Q4 2024.
  • Year-over-year, Depreciation & Amortization (CF) increased in four of the last six quarters, with growth averaging 1.0%.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q3 2021 (growth of 248.1%), and the weakest in Q4 2025 (a decline of 35.3%).
  • Business Quant data shows AZN's Depreciation & Amortization (CF) at $1.37 billion (Q1 2026), $1.51 billion (Q4 2025) and $1.55 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 1.96 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 194.00 Mn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn -
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn 1.93 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 98.00 Mn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 1.62 Bn
10 Vertex Pharmaceuticals 129.23 Bn 101.23 Bn 2.84 Bn 56.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.93 Bn
Mar 31, 2026 1.37 Bn
Dec 31, 2025 1.51 Bn
Sep 30, 2025 1.55 Bn
Jun 30, 2025 1.39 Bn
Mar 31, 2025 1.28 Bn
Dec 31, 2024 2.34 Bn
Sep 30, 2024 1.82 Bn
Jun 30, 2024 1.28 Bn
Mar 31, 2024 1.26 Bn
Jun 30, 2023 1.28 Bn
Mar 31, 2023 1.50 Bn
Jun 30, 2022 1.36 Bn
Mar 31, 2022 1.31 Bn
Dec 31, 2021 2.19 Bn
Sep 30, 2021 2.79 Bn
Jun 30, 2021 753.00 Mn
Mar 31, 2021 797.00 Mn
Dec 31, 2020 797.00 Mn
Sep 30, 2020 801.00 Mn
API Access

Astrazeneca Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=AZN&period=max&api_key=YOUR_API_KEY